Eurand to Present at Barclays Capital Global Healthcare Conference

CARLSBAD, Calif.--(BUSINESS WIRE)--Verdezyne, Inc., a privately-held synthetic biology company developing processes for the industrial chemicals and fuel markets, today announced the appointment of Damien Perriman to the position of vice president of business development.

MORE ON THIS TOPIC